ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology.

Biotechnology

ISA Pharmaceuticals

Leon Hooftman

Kees Melief

Miranda Molenaar

Begoña Aguilera

Marie-Andrée Yessine

Dominique Würth

Emine Şekerdağ Kılıç, PhD

Project Management

Scientific Research Team

Business Development and Strategy

Leadership Team

Research and Development

Clinical Project Management

Teams at ISA Pharmaceuticals